An iron dextran infusion is a medical treatment where iron dextran, a complex of iron and dextran, is administered intravenously to rapidly correct severe iron deficiency anemia. This method bypasses the digestive system, allowing for faster and more effective iron replenishment than oral supplements.
The infusion delivers iron directly into the bloodstream, where it is transported to the bone marrow to produce red blood cells. Iron dextran is a stable form of iron that minimizes the risk of allergic reactions compared to other intravenous iron formulations. The process typically takes one to two hours, during which a healthcare provider monitors the patient for any adverse reactions.
Iron dextran infusions come in two forms: low-molecular-weight and high-molecular-weight. Low-molecular-weight iron dextran is generally preferred due to its lower risk of allergic reactions. The infusion is usually given in a clinical setting, such as a hospital or outpatient clinic, under the supervision of a healthcare professional.
| Type | Molecular Weight | Administration Time |
|---|---|---|
| Low-molecular-weight iron dextran | Low | 1 hour |
| High-molecular-weight iron dextran | High | 2 hours |
This treatment is reserved for patients with severe iron deficiency anemia who cannot tolerate oral iron supplements or require rapid iron replenishment. Common conditions include chronic kidney disease, gastrointestinal disorders, and heavy menstrual bleeding. It is also used preoperatively in patients scheduled for major surgeries who are at risk of significant blood loss.
Many people confuse iron dextran infusions with other forms of iron therapy, such as ferric carboxymaltose or ferumoxytol. While all are intravenous iron treatments, iron dextran has been used longer and is associated with a higher risk of allergic reactions, though this risk is mitigated with the low-molecular-weight formulation. Another misconception is that the infusion is painful; however, it is generally well-tolerated, with most patients experiencing only mild discomfort at the injection site.
I once observed an iron dextran infusion being administered to a patient with chronic kidney disease. The process was straightforward, and the patient reported minimal side effects, confirming the treatment's effectiveness and safety when properly managed.